Evaluation of Premalignant and Malignant Lesions during the Induction of Mouse Melanomas

Cancer Research

Volumn 47, Issue 5, 1987, Pages 1251-1254

  Oxenhandler, Ronald W ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CROTON OIL;

ANIMAL EXPERIMENT; CARCINOGENESIS; HISTOLOGY; HISTOPATHOLOGY; MALIGNANT TRANSFORMATION; MELANOMA; MOUSE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TRANSPLANTATION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMAL; FEMALE; LYMPH NODES; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEVUS, PIGMENTED; PRECANCEROUS CONDITIONS; SKIN; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023115892     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Berkelhammer, J., Oxenhandler, R. W., Hook, R. R., Jr., and Hennessy, J. M. Development of a new melanoma model in CS7BL/6 mice. Cancer Res., 42:3157-3163, 1982.
2. Berkelhammer, J., Luethans, T. N., Hook, R. R., Jr., and Oxenhandler, R. W. Phenotypic instability of mouse melanomas after propagation in vivo and in vitro. Cancer Res., 46: 2923-2928, 1986.
3. Takizawa, H., Sato, S., Kitajima, H., Konishi, S., Iwata, K., and Hayashi, Y. Carcinogenesis (Lond.), 6:921-923, 1985.
4. Berkelhammer, J., Mastrangelo, M. J., Laucius, J. F., Bodurtha, A. J., and Prehn, R. T. Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors. Int. J. Cancer, 16:571-578, 1975.
5. Jundt, G., Schulz, A., Paul, E., Cochran, A. J., and Herschman, H. R. S-100 protein in amelanotic melanoma: a convenient immunocytochemical approach compared to electron microscopy. Pathol. Res. Pract., 181: 37–44, 1986.
6. Langley, R. Practical Statistics Simply Explained, Chap. 6, pp. 137–322. New York: Dover Publications, Inc., 1971.
7. Bhawan, J. Melanocytic nevi: a review. J. Cutaneous Pathol., 6: 153–169, 1979.
8. Stoll, H. L., Jr. Squamous cell carcinoma. In: F. Helm (ed), Cancer Derma-tology, Chap. 10, pp. 113–132. Philadelphia, PA: Lea & Febiger, 1979.
9. systems. 9. Clark, W. H., Min, B. H., and Kligman, L. H. L. The developmental biology of induced malignant melanoma in guinea pigs and a comparison with other neoplastic Cancer Res., 36:4079-4091, 1976.
10. Pawlowski, A., Haberman, H. F., and Menon, A. I. Skin melanoma induced by 7, 12-dimethylbenzanthracene in albino guinea pigs and its similarities to skin melanoma of humans. Cancer Res., 40:3562-3660, 1980.
11. Pawlowski, A., and Lea, P. J. Nevi and melanoma induced by chemical carcinogens in laboratory animals: similarities and differences with human lesions. J. Cutaneous Pathol., 10:81-110, 1983.
12. Epstein, J. H., Epstein, W. L., and Nakai, T. Production of melanomas from DMBA-induced “blue nevi” in hairless mice with ultraviolet light. J. Natl. Cancer Inst., 38:19-30, 1967.
13. Kripke, M. L. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J. Natl. Cancer Inst., 63:541-548, 1979.
14. Fidler, I. J., and Kripke, M. L. Metastatic heterogeneity of cells from the K-1735 melanoma. In: E. Grundemann (ed.), Metastatic Tumor Growth, Cancer Campaign, Vol. 4, pp. 71–81. Stuttgart: Gustav Fischer Verlag, 1980.
15. Fidler, I. J., Grays, E., Cifone, M. A., and Barnes, Z. Demonstration of multiple phenotypic diversity in a murine melanoma of recent origin. J. Natl. Cancer Inst., 67:947-956, 1981.
16. Rieber, M., and Rieber, M. S. Improved detection of labile cell surface components with zinc chloride-aprotinin: demonstration of glycoprotein differences in K-1735 metastatic melanoma variants. Int. J. Cancer, 36:623-628, 1985.
17. Herlyn, D., Elder, D. E., Bondi, E., Atkinson, B., Guerry, D., IV, Koprowski, H., and Clark, W. H., Jr. Human cutaneous nevi transplanted onto nude mice: a model for the study of the lesional steps in tumor progression. Cancer Res., 46:1339-1343, 1986.
18. Nowell, P. Mechanisms of tumor progression. Cancer Res., 46:2203-2207, 1986.
19. Greene, M. H., Clark, W. H., Tucker, M. A., Elder, D. E., Kraemer, K. H., Guerry, D., Witmer, W. K., Thompson, J., Matozzo, I., and Fraser, M. Acquired precursors of cutaneous malignant melanoma: the familial dysplastic nevus syndrome. N. Engl. J. Med., 312:91-97, 1985.
20. Perera, M. I. R., Um, K. I., Greene, M. H., Waters, H. L., Bredberg, A., and Kraemer, K. H. Hereditary dysplastic nevus syndrome: lymphoid cell ultraviolet hypermutability in association with increased melanoma susceptibility. Cancer Res., 46:1005-1009, 1986.